As European markets navigate a landscape marked by mixed performances across major indices and persistent inflationary pressures, small-cap stocks present intriguing opportunities for investors seeking growth potential amidst economic fluctuations. In this context, identifying companies with strong fundamentals and insider activity can offer valuable insights into promising investment avenues within the small-cap sector. Top 10 Undervalued Small Caps With Insider Buying In Europe Name PE PS Discount to Fair Value Value Rating Kitwave Group 13.1x 0.3x 45.00% ★★★★★☆ Hoist Finance 9.2x 1.9x 15.64% ★★★★☆☆ CVS Group 44.1x 1.3x 40.37% ★★★★☆☆ Seeing Machines NA 2.8x 45.33% ★★★★☆☆ Troax Group 31.7x 2.8x 25.59% ★★★☆☆☆ A.G. BARR 19.9x 1.9x 45.10% ★★★☆☆☆ Yubico 33.4x 4.8x -13.81% ★★★☆☆☆ NOTE 21.7x 1.5x -10.72% ★★★☆☆☆ Oxford Instruments 43.5x 2.3x 0.53% ★★★☆☆☆ WithSecure Oyj NA 1.4x -0.97% ★★★☆☆☆ Click here to see the full list of 54 stocks from our Undervalued European Small Caps With Insider Buying screener. Let's explore several standout options from the results in the screener. Coats Group Simply Wall St Value Rating: ★★★★★☆ Overview: Coats Group is a global leader in industrial thread manufacturing, serving the apparel, footwear, and performance materials sectors with a market capitalization of approximately $1.19 billion. Operations: The company generates revenue primarily from three segments: Apparel ($775.30 million), Footwear ($405.20 million), and Performance Materials ($321.80 million). Over the analyzed periods, the net income margin showed an upward trend, reaching 7.23% by mid-2024 before slightly decreasing to 5.58% in mid-2025. The cost of goods sold (COGS) consistently constitutes a significant portion of expenses, influencing gross profit margins which have fluctuated over time, peaking at 37.13% in mid-2024 before settling at 36.87% by mid-2025. PE: 23.3x Coats Group, a small company in Europe, shows potential with forecasted earnings growth of 27.56% annually. Despite recent share dilution through a £242 million equity offering on July 17, 2025, insider confidence is notable as insiders have been purchasing shares. The company's financials reveal sales of US$705 million for the first half of 2025 and consistent dividends with an increase to 1 cent per share. However, its debt coverage by operating cash flow remains insufficient. Click here to discover the nuances of Coats Group with our detailed analytical valuation report. Gain insights into Coats Group's historical performance by reviewing our past performance report.LSE:COA Share price vs Value as at Jul 2025 Borregaard Simply Wall St Value Rating: ★★★☆☆☆ Story Continues Overview: Borregaard operates as a biochemicals company specializing in bio-based products derived from wood, with a market cap of approximately NOK 11.68 billion. Operations: The company generates revenue primarily from Bio Solutions, Bio Materials, and Fine Chemicals, with Bio Solutions being the largest contributor. The gross profit margin shows a notable trend, reaching 64.52% by March 2025. Operating expenses include significant general and administrative costs. PE: 22.2x Borregaard, a European small-cap company, recently reported second-quarter sales of NOK 2,045 million and net income of NOK 255 million, showing consistent growth from the previous year. Insider confidence is evident as Tove Andersen purchased 2,000 shares valued at approximately NOK 375,840 in June. This indicates potential optimism about future performance. Despite relying entirely on external borrowing for funding—considered higher risk—the company expects earnings to grow by over 11% annually. With strong agricultural sales driving volumes and a leadership change imminent in August with Erik Foss-Jacobsen as CEO, Borregaard remains an intriguing prospect amidst evolving market dynamics. Delve into the full analysis valuation report here for a deeper understanding of Borregaard. Review our historical performance report to gain insights into Borregaard's's past performance.OB:BRG Share price vs Value as at Jul 2025 Hanza Simply Wall St Value Rating: ★★★★☆☆ Overview: Hanza is a manufacturing solutions provider that offers comprehensive services in product development, sourcing, and production, with a market cap of approximately SEK 2.45 billion. Operations: Revenue primarily comes from operations with a significant cost of goods sold (COGS) component, impacting the gross profit margin, which was 44.06% as of September 2024. Operating expenses are substantial and include general and administrative costs, which reached SEK 1,613 million in the same period. The net income margin has shown variability over time but stood at 2.74% during this period. PE: 31.7x Hanza, a European company with a smaller market cap, has shown significant growth potential despite its reliance on external borrowing. Recent earnings reports highlight impressive sales growth, reaching SEK 1.5 billion in Q2 2025 from SEK 1.2 billion the previous year, and net income rising to SEK 52 million from SEK 6 million. Earnings per share also increased notably. Insider confidence is evident through recent share purchases by insiders over the past few months, indicating positive sentiment towards future performance amidst forecasts of substantial earnings growth at over 34% annually. Take a closer look at Hanza's potential here in our valuation report. Examine Hanza's past performance report to understand how it has performed in the past.OM:HANZA Share price vs Value as at Jul 2025 Where To Now? Gain an insight into the universe of 54 Undervalued European Small Caps With Insider Buying by clicking here. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Interested In Other Possibilities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LSE:COA OB:BRG and OM:HANZA. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
European Undervalued Small Caps With Insider Action To Explore In July 2025
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...